PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Images capture split personality of dense suspensions

Images capture split personality of dense suspensions
2012-04-02
(Press-News.org) Stir lots of small particles into water, and the resulting thick mixture appears highly viscous. When this dense suspension slips through a nozzle and forms a droplet, however, its behavior momentarily reveals a decidedly non-viscous side. University of Chicago physicists recorded this surprising behavior in laboratory experiments using high-speed photography that can capture action taking place in one hundred-thousandths of a second or less.

UChicago graduate student Marc Miskin and Heinrich Jaeger, the William J. Friedman and Alicia Townsend Friedman Professor in Physics, expected that the dense suspensions in their experiments would behave strictly like viscous liquids, which tend to flow less freely than non-viscous liquids. Viscosity certainly does matter as the particle-laden liquid begins to exit the nozzle, but not at the moment where the drop's thinning neck breaks in two.

New behavior appears to arise from feedback between the tendencies of the liquid and what the particles within the liquid can allow. "While the liquid deforms and becomes thinner and thinner at a certain spot, the particles also have to move with that liquid. They are trapped inside the liquid," Jaeger explained. As deformation continues, the particles get in each other's way.

"Oil, honey, also would form a long thread, and this thread would become thinner and break in a way characteristic of a viscous liquid," Jaeger said. "The particles in a dense suspension conspire to interact with the liquid in a way that, when it's all said and done, a neck forms that shows signs of a split personality: It thins in a non-viscous fashion, like water, all the while exhibiting a shape more resembling that of its viscous cousins."

It took Miskin and Jaeger six months to become convinced that the viscosity of the suspending liquid was a minor player in their experiments. "It is a somewhat heretical view that this viscosity should not matter," Jaeger said. "Who would have thought that?"

Miskin and Jaeger presented their results in the March 5 online early edition and the March 20 print edition of the Proceedings of the National Academy of Sciences.

In their experiments, Miskin and Jaeger compared a variety of pure liquids to mixtures in which particles occupy more than half the volume.

"The results indicate that what we know about drop breakup from pure liquids does not allow us to predict phenomena observed in their experiments," said Jeffrey Morris, professor of chemical engineering at City College of New York. "The most striking and interesting result is the fact that, despite these being very viscous mixtures, the viscosity plays little role in the way a drop forms."

Few studies have examined droplet formation in dense suspensions. As Morris noted, such work could greatly impact applications such as inkjet printing, combustion of slurries involving coal in oil, and the drop-by-drop deposition of cells in DNA microarrays.

Scientific Defiance

In these applications particles often are so densely packed that their behavior defies a simple scientific description, one that might only take into account average particle size and the fraction of the liquid that the particles occupy, Morris explained. The UChicago study showed that particles cause deformations and often protrude through the liquid, rendering any such description incomplete until fundamental questions about the interface between a liquid mixture and its surroundings are properly addressed.

"Miskin and Jaeger provide arguments for the importance of these protrusions in their work and suggest that the issue is of broader relevance to any flow where a particle-laden liquid has an interface with another fluid," Morris said.

Miskin and Jaeger verified their results by systematically evaluating different viscosities, particle sizes and suspending liquids, and developed a mathematical model to explain how the droplet necks evolve over time until they break apart.

One initially counter-intuitive prediction of this model was that larger particles should produce behavior resembling that in pure water without any particles. "If you want to make it behave more like a pure non-viscous liquid, you want to make the particles large," said Jaeger, who finds himself intrigued by nature's seemingly endless store of surprises.

Miskin and Jaeger indeed observed this when the particle size approached a significant fraction of the nozzle diameter, making the particles visible to the naked eye.

"You think you have a pretty good idea of what should happen, and instead there's a surprise at every corner. Honestly, finding surprises is what I love about this work," Jaeger said.



INFORMATION:

Citation: "Droplet formation and scaling in dense suspensions," by Marc Z. Miskin and HeinrichM. Jaeger, Proceedings of the National Academy of Sciences, March 20, 2012, Vol. 109, No. 12, page 4389-4394.

Funding: National Science Foundation and the Keck Initiative for Ultrafast Imaging at the University of Chicago.


[Attachments] See images for this press release:
Images capture split personality of dense suspensions

ELSE PRESS RELEASES FROM THIS DATE:

Tokai Pharmaceuticals' galeterone well-tolerated in patients with advanced prostate cancer

2012-04-02
CAMBRIDGE, Mass. and CHICAGO, Ill. -- Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that its lead candidate galeterone (TOK-001) was well-tolerated with minimal side effects and demonstrated efficacy in patients with castration-resistant prostate cancer (CRPC) in a Phase 1 study. The data will be presented in an oral presentation titled, "ARMOR1: Safety of galeterone (TOK-001) in a Phase 1 clinical trial in chemotherapy naïve patients with castration-resistant prostate cancer (CRPC)," abstract ...

Early clinical data show galeterone safe, effective against prostate cancer

2012-04-02
CHICAGO — Patients with castration-resistant prostate cancer had limited side effects and in many cases a drop in prostate-specific antigen expression with galeterone (TOK-001), a small-molecule oral drug, according to phase I data presented at the AACR Annual Meeting 2012, held here March 31 - April 4. Castration-resistant prostate cancer (CRPC) is an advanced form of prostate cancer that occurs when the disease progresses after treatment with androgen deprivation therapy. Galeterone works against CRPC by blocking the androgen receptor, reducing levels of the ligand ...

Metformin appeared to slow prostate cancer growth

2012-04-02
CHICAGO — The use of metformin in men with prostate cancer before prostatectomy helped to reduce certain metabolic parameters and slow the growth rate of the cancer, according to the results of a phase II study. Anthony M. Joshua, M.B.B.S., Ph.D., staff medical oncologist at the Princess Margaret Hospital, University Health Network in Toronto, Ontario, Canada, presented the data at the AACR Annual Meeting 2012, held here March 31 - April 4. Metformin is the most commonly prescribed medication for diabetes. Prior laboratory research has suggested that metformin may ...

Biomarker identified in relation to drug response in refractory urothelial cancer

2012-04-02
CHICAGO — The antiangiogenic drug pazopanib has demonstrated clinically meaningful activity in patients with refractory urothelial cancer, according to results presented at the AACR Annual Meeting 2012, held here March 31 - April 4. The results also revealed that increases in interleukin-8 levels early after treatment with pazopanib may predict a lack of tumor response to the therapy. "Historically, prognosis of patients with relapsed or refractory urothelial cancer is quite dismal," said Andrea Necchi, M.D., faculty member in the department of medicine at Fondazione ...

Towards TB elimination: ECDC and ERS introduce new guidelines on tuberculosis care in Europe

2012-04-02
Today, the European Respiratory Society (ERS) and the European Centre for Disease Prevention and Control (ECDC) publish their jointly developed European Union Standards for Tuberculosis Care (ESTC). The 21 patient-centred standards aim to guide clinicians and public health workers to ensure optimal diagnosis, treatment and prevention of tuberculosis (TB) in Europe – with nearly 74,000 reported TB cases in the EU/EEA in 2010 clearly showing that TB remains a public health challenge across the region. The new EU-specific guidelines were developed by a panel of 30 experts ...

Oxygen in tumors predicts prostate cancer recurrence

2012-04-02
TORONTO -- Low oxygen levels in tumors can be used to predict cancer recurrence in men with intermediate-risk prostate cancer even before they receive radiation therapy. The clinical research, led by radiation oncologists at the Princess Margaret Hospital (PMH) Cancer Program, University Health Network (UHN) is published online today in Clinical Cancer Research, a journal of the American Association for Cancer Research (doi: 10.1158/1078-0432.CCR-11-2711). "We've not only shown that men do worse if they have low oxygen levels (hypoxia) in their prostate cancer, but ...

2 targeted therapies act against Ewing's sarcoma tumors

2012-04-02
CHICAGO - A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors, according to research led by investigators from The University of Texas MD Anderson Cancer Center reported at the AACR Annual Meeting 2012. Five of 17 Ewing's sarcoma patients responded to the combination, with two achieving complete responses, one for 27 weeks. The researchers noted that the ability to manage patients' treatment-related side effects is vital to maintaining the therapy and slowing disease progression. ...

Commonly used diabetes drug may help to prevent primary liver cancer

2012-04-02
Baltimore, MD – March 31, 2012. Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research. Primary liver cancer, or hepatocellular carcinoma, is an often-deadly form of cancer that is on the rise worldwide and is the fastest-growing cause of cancer-related deaths among American men. Patients with Type II diabetes have a two- to three-fold increased relative risk of developing primary ...

Transforming scar tissue into beating hearts: The next instalment

2012-04-02
London -- The latest research developments to reprogram scar tissue resulting from myocardial infarction (MI) into viable heart muscle cells, were presented at the Frontiers in CardioVascular Biology (FCVB) 2012 meeting, held 30 March to 1 April at the South Kensington Campus of Imperial College in London. In a keynote lecture Dr Deepak Srivastava outlined his approach that has been described as a "game changer" with the potential to revolutionise treatment of MI. For the first time at the FCVB meeting, Srivastava presented the results of his latest studies using ...

Second mutation in BRAF-mutated melanoma doesn't contribute to resistance

2012-04-02
A second mutation found in the tumors of patients with BRAF-mutated metastatic melanoma does not contribute to resistance to BRAF inhibitor drugs, a finding that runs counter to what scientists expected to be true. The study by researchers at UCLA's Jonsson Comprehensive Cancer Center found that patients with the mutations in both the MEK1 and BRAF genes respond as well to the inhibitors as patients with the BRAF mutation alone. Another surprising finding is that the MEK1 and BRAF mutations exist together in these patients, despite the fact that they drive ...

LAST 30 PRESS RELEASES:

Noise pollution is affecting birds' reproduction, stress levels and more. The good news is we can fix it.

Researchers identify cleaner ways to burn biomass using new environmental impact metric

Avian malaria widespread across Hawaiʻi bird communities, new UH study finds

New study improves accuracy in tracking ammonia pollution sources

Scientists turn agricultural waste into powerful material that removes excess nutrients from water

Tracking whether California’s criminal courts deliver racial justice

Aerobic exercise may be most effective for relieving depression/anxiety symptoms

School restrictive smartphone policies may save a small amount of money by reducing staff costs

UCLA report reveals a significant global palliative care gap among children

The psychology of self-driving cars: Why the technology doesn’t suit human brains

Scientists discover new DNA-binding proteins from extreme environments that could improve disease diagnosis

Rapid response launched to tackle new yellow rust strains threatening UK wheat

How many times will we fall passionately in love? New Kinsey Institute study offers first-ever answer

Bridging eye disease care with addiction services

Study finds declining perception of safety of COVID-19, flu, and MMR vaccines

The genetics of anxiety: Landmark study highlights risk and resilience

How UCLA scientists helped reimagine a forgotten battery design from Thomas Edison

Dementia Care Aware collaborates with the Institute for Healthcare Improvement to advance age-friendly health systems

Growth of spreading pancreatic cancer fueled by 'under-appreciated' epigenetic changes

Lehigh University professor Israel E. Wachs elected to National Academy of Engineering

Brain stimulation can nudge people to behave less selfishly

Shorter treatment regimens are safe options for preventing active tuberculosis

How food shortages reprogram the immune system’s response to infection

The wild physics that keeps your body’s electrical system flowing smoothly

From lab bench to bedside – research in mice leads to answers for undiagnosed human neurodevelopmental conditions

More banks mean higher costs for borrowers

Mohebbi, Manic, & Aslani receive funding for study of scalable AI-driven cybersecurity for small & medium critical manufacturing

Media coverage of Asian American Olympians functioned as 'loyalty test'

University of South Alabama Research named Top 10 Scientific Breakthroughs of 2025

Genotype-specific response to 144-week entecavir therapy for HBeAg-positive chronic hepatitis B with a particular focus on histological improvement

[Press-News.org] Images capture split personality of dense suspensions